Fingerprint
Dive into the research topics of 'PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of akt and EGFR'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of akt and EGFR
Martin L. Sos, Mirjam Koker, Barbara A. Weir, Stefanie Heynck, Rosalia Rabinovsky, Thomas Zander, Jens M. Seeger, Jonathan Weiss, Florian Fischer, Peter Frommolt, Kathrin Michel, Martin Peifer, Craig Mermel, Luc Girard, Michael Peyton, Adi F. Gazdar, John D. Minna, Levi A. Garraway, Hamid Kashkar, William Pao
Research output: Contribution to journal › Article › peer-review
454
Scopus
citations